Diana Hausman's Net Worth
$6.61 Million
Who is Diana Hausman?
Diana Hausman has an estimated net worth of $6.61 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., Zymeworks Inc., Immuneering Corp, and Zentalis Pharmaceuticals, Inc..
SEC CIK
Diana Hausman's CIK is 0001563992
Past Insider Trading and Trends
2020 was Diana Hausman's most active year for acquiring shares with 14 total transactions. Diana Hausman's most active month to acquire stocks was the month of November. 2020 was Diana Hausman's most active year for disposing of shares, totalling 14 transactions. Diana Hausman's most active month to dispose stocks was the month of November. 2022 saw Diana Hausman paying a total of $327,600.00 for 31,385 shares, this is the most they've acquired in one year. In 2020 Diana Hausman cashed out on 130,000 shares for a total of $3,179,278.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Oncothyreon Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
|
∞
| 5.75K |
$4.65 | $26,723.55 | 5.75K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zymeworks Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.99% | 1.45K |
$34.95 | -$36,631.27 | 5.38K |
Scheduled
|
Mar 10
| ||
Form 4
| +5.57% | 207 |
$30.92 | $6,400.44 | 3.92K |
Jan 7
| |||
Form 4
|
—
|
0
|
$33.00 | -$266,814.12 | 3.72K |
Scheduled
|
Dec 4
| ||
Form 4
|
—
|
0
|
$33.29 | -$830,804.61 | 3.72K |
Scheduled
|
Dec 1 - Dec 2
| ||
Form 4
|
—
|
0
|
$29.32 | -$1,254,500.00 | 3.72K |
Scheduled
|
Sep 14
| ||
Form 4
| +10.95% | 367 |
$30.66 | $11,252.22 | 3.72K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +11.00% | 332 |
$19.54 | $6,487.28 | 3.35K |
Jan 8
| |||
Form 4
| +20.81% | 520 |
$12.49 | $6,494.80 | 3.02K |
Jul 8
| |||
Form 4
| +24.95% | 499 |
$12.48 | $6,227.52 | 2.5K |
Jan 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Immuneering Corp (IMRX) Snapshot price: $6.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $11.355
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.89% | -3.36K |
$12.62 | -$42,352.72 | 373.88K |
May 9
| |||
Form 4
| +849.44% | 337.5K |
—
|
—
| 377.23K |
Feb 1
| |||
Form 4
|
∞
| 39.73K |
—
|
—
| 39.73K |
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||